Form D · Pharmaceuticals
Galera Therapeutics, Inc.
Malvern, PA · CIK 0001563577
Offering snapshot reported Jan 14, 2025 · SEC filing
- Reported sold
- $2.89M Offering amount: $2.89M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 30, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 14, 2025 | Initial | $2,885,000 | No comparison | 8 | SEC filing |
| Jan 13, 2025 | Initial | $2,738,355 | No comparison | 18 | SEC filing |
| Sep 17, 2018 | Initial | $70,185,418 | No comparison | 23 | SEC filing |
| Nov 28, 2016 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Oct 14, 2015 | Initial | $37,102,500 | No comparison | 7 | SEC filing |
| Aug 6, 2014 | Initial | $4,740,000 | No comparison | 7 | SEC filing |
| Dec 10, 2012 | Initial | $11,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-535076
Source: Form D, filed Jan 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lawrence Alleva | Director |
| James Barrett | Director |
| Robert A. Beardsley | Director, Executive |
| Robert J. Calcaterra | Director |
| Nancy T. Chang | Director |
| Thomas Dyrberg | Director |
| Arthur Fratamico | Executive |
| Michael R. Friedman | Director |
| Eric Gulve | Director |
| Jon T. Holmlund | Executive |
| Jeffery L. Keene | Executive |
| Kevin Lokay | Director |
| Campbell Murray | Director |
| Michael Powell | Director |
| Dennis P. Riley | Executive |
| Stephen Ross | Executive |
| Michal Silverberg | Director |
| Henry Skinner | Director |
| Mel Sorensen | Director, Executive |
| J. Mel Sorensen | Director, Executive |
| Joel Sussman | Executive |
| Frank Torti | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
45 Liberty Boulevard Suite 230
Malvern, PA, 19355
Malvern, PA, 19355